Bimekizumab Efficacy Through 3 Years in Patients With Moderate to Severe Plaque Psoriasis: Long-Term Pooled Analysis from BE BRIGHT. J of Skin 2024, 8 (1), s307. https://doi.org/10.25251/skin.8.supp.307.